Daily treatment with the antiviral drug tenofovir during the third trimester of pregnancy significantly reduced the risk of hepatitis B (HBV) transmission from mother to baby, according to new US research. The findings of the study could potentially help to eradicate...
Women with congenital heart disease are more likely to have safer pregnancies, according to new research. Physicians may have been over-estimating the risks of complications for women with these disorders, which in turn may have been discouraging them from pregnancy,...
Gestational diabetes may increase a child’s later risk of obesity, new research has found. Maternal gestational diabetes (GDM) is associated with increased odds of offspring obesity at age 9 to 11 years, suggested the multinational study of more than 4,700 children,...
Newer epilepsy medications may not have a negative impact on a baby’s cognitive development if taken during pregnancy, new research has determined. Risks associated with an older medication, valproate, were also confirmed during the latest study, however, the...
The Pregnancy Summit, held in London in early October, was an opportunity to hear about some of the latest science related to pregnancy and fetal health medicine. The Pregnancy and Medicine Initiative was present at the conference, which took place simultaneously with...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
Recent Comments